JILGYUNGYI Co., Ltd.

JILGYUNGYI Co., Ltd.

KKRX:233990
641.00
KRW
+1.00
(+0.16%)
218.74EPS
8.82P/E
30.93BMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
569.87
901.17
1,535.25
1,600.4
1,634.45
880.37
739.36
651.69
498.02
678.73
880.69
Basic EPS, GAAP
-565
-1,097
-130
-226
-89
-79
-159
-79
-23
54
237.52
Free Cash Flow per Basic Share
48.17
-351.71
-289.85
-132.88
0.05
-79.02
1.92
-63.54
7.78
26.3
-110.1
Dividend per Share
4.96
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-431.36
517.89
449.35
329.15
293.76
203.38
46.76
-30.57
146.43
202.18
440.37
Tangible Book Value per Share
-527.17
449.24
384.26
266.72
236.94
154.99
12.35
-54.71
132.15
177.86
417.42
Basic Weighted Avg Shares
10
13
13
13
14
14
14
14
15
15
15
Sales/Revenue/Turnover
5,833
11,297
20,556
21,534
22,276
12,279
10,336
9,091
7,358
10,007
13,003
Operating Margin (%)
18.69
4.9
-9.29
-12.74
0.09
-10.91
-18.35
-10.68
-1.67
10.6
19.34
Depreciation Expense
92
366
602
821
1,209
1,049
843
665
452
560
695
Net Income, GAAP
-5,783
-13,752
-1,741
-3,041
-1,213
-1,102
-2,223
-1,102
-340
796
3,507
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-99.15
-121.73
-8.47
-14.12
-5.45
-8.97
-21.51
-12.12
-4.62
7.96
26.97
Working Capital
4,777
1,414
-1,097
-2,613
-1,439
-1,192
-3,274
-3,655
-2,714
-1,599
746
LT Debt
359
422
2,178
2,874
633
493
279
193
287
344
2,696
Total Equity
-4,417
6,960
6,039
4,424
4,072
2,856
653
-427
2,162
2,985
6,502
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-26.78
-58.13
-28.45
-31.74
-127.25
- -
- -
30.94
73.93

Capital Structure

KRW

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

KRW

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-102.84%
-138.6%
117.81%
Free Cash Flow
-17,094.27%
-780.67%
-519.18%
Net Income, GAAP
4.42%
-2.34%
340.46%
Sales/Revenue/Turnover
15.8%
3.8%
29.94%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
7,358
2024
- -
- -
- -
- -
10,007
2025
- -
- -
- -
- -
13,003

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-23
2024
- -
- -
- -
- -
54
2025
- -
- -
- -
- -
237.52

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

CEO
Won-Seok Choi
Full Time Employees
40
Sector
Consumer non-durables
Industry
Household/Personal care
Address
Seoul South Korea
IPO Date
Dec 29, 2015
Business
JILGYUNGYI Co., Ltd. is a South Korean healthcare and personal care company specializing in feminine intimate hygiene, personal care cosmetics, and biopharmaceutical research and development for women's health. Founded in October 2009 and headquartered in Seoul, South Korea, the company operates primarily through two core business divisions: Cosmetics and Pharmaceuticals. JILGYUNGYI develops, manufactures, and markets a comprehensive portfolio of intimate and wellness solutions, comprising solid tablet-form feminine cleansers under its signature JilGyungYi brand; foam, gel, and liquid washes including Daily Ecoa Wash Pure Foam and Evening Rub Gel; pre-filled syringe-applicator feminine essences such as 2X InnerBalance; specialized feminine wipes and Y-zone care mists; brightening and moisturizing formulations including Sunshine Tone-Up Cream; eco-friendly sanitary napkins and panty liners featuring natural cornstarch-derived top sheets under the Maeum brand; specialized men's personal hygiene cleansers under the Manner Man line; functional dietary supplements including women's lactic acid probiotics; and electronic intimate cleansing devices such as Hwantastic. Through its pharmaceutical research division, the company develops patent-backed bio-therapeutic compositions, focusing on non-antibiotic vaginitis treatments, urinary incontinence therapeutic candidates, and mucosal drug delivery technologies. JILGYUNGYI serves retail consumers and healthcare channels domestically across South Korea via e-commerce channels, television home shopping networks, health and beauty store chains, and pharmacies. Geographically, the company exports its products internationally across North America, Europe, and Asia-Pacific, with key overseas markets including China, the United States, Japan, Indonesia, Vietnam, Thailand, Singapore, and the Philippines. In recent strategic developments, the company rebranded from Ha U Dong Chun Co., Ltd. to JILGYUNGYI Co., Ltd. to strengthen global brand recognition, established localized operational subsidiaries and cross-border live-commerce distribution networks in Greater China, expanded its market reach across Southeast Asia by securing MUI Halal certification for its core intimate wash lineup, and systematically diversified its portfolio from feminine hygiene into comprehensive gender-inclusive personal care, eco-friendly menstrual care, and preventive inner-beauty nutrition.